On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
MondayAug 13, 2018 10:50 am

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Companies Gain Traction in US Medical Cannabis Space

FinCanna’s royalty finance model could be a game changer for companies needing capital while operating in the U.S. medical cannabis space Pilot marketing program offering HIPAA-compliant point-of-sale solution and inventory tracking system launched in California’s medical cannabis marketplace The U.S. medical cannabis market is projected to grow at 11.8 percent CAGR through 2025 from $5.1 billion to an estimated $12.5 billion in 2025 (New Frontier Data) FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF), a royalty company focused on becoming the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry, continues to gain momentum…

Continue Reading

FridayAug 10, 2018 2:37 pm

Cannabis Strategic Ventures, Inc. (NUGS) Prepares to Uplist with Renewed Focus on Financial Reporting

Cannabis Strategic Ventures working toward fully reporting status with SEC, OTC exchange Company’s portfolio includes professional staffing services, high-quality cannabis oils Cannabis industry expected to be responsible for more than 600,000 jobs by 2025 Cannabis Strategic Ventures, Inc. (OTC: NUGS) has pursued its mission to foster legalized cannabis industry value-adds by building a portfolio of vertically integrated companies, and now the company is preparing to uplist on the public markets by refocusing its efforts on bringing its financial reporting up to par. “While building on our business portfolio is very important to us, bringing the Company up to fully reporting…

Continue Reading

FridayAug 10, 2018 12:09 pm

ChineseInvestors.com, Inc.’s (CIIX) CBD Division Holds Promise, as Detailed in MoneyTV Interview

CBD division offers potential for shareholders, as shared on MoneyTV Over 70 retail establishments offering ChineseHempOil.com products in Los Angeles Ground work for wholly owned subsidiary focused on CBD products began in 2016 Continued commitment to cryptocurrency education for the Chinese-speaking community worldwide ChineseInvestors.com, Inc. (OTCQB: CIIX), a company focused on providing financial information and services to the Chinese-speaking community worldwide, will soon spin off its cannabis-related products into the wholly owned subsidiary ChineseHempOil.com, Inc. The spinoff was originally scheduled for May 31, 2018, but was temporarily postponed as CIIX continues to develop domestic sales channels. CEO Warren Wang joined…

Continue Reading

ThursdayAug 09, 2018 11:23 am

Earth Science Tech, Inc. (ETST) Thinking of the Future in the CBD Space

The company is working to be a major provider of premier CBD products ETST’S three subsidiaries focus on developing its role as a global leader in the CBD space ETST is forward-thinking – centering on the science, research and studies of its high-grade hemp CBD oil Based in Doral, Florida, Earth Science Tech, Inc. (OTC: ETST) is a biotechnology company with three wholly owned subsidiaries. Through these, it operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. CBD offered by the company is in the form of vitamins, minerals, herbs, botanicals, personal care…

Continue Reading

WednesdayAug 08, 2018 12:58 pm

Investment Researchers Peg Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) as Example of ‘Badly Mispriced’ Stock with Return Potential

Beacon Securities Limited argues that Sunniva’s Canadian greenhouse alone is worth more than its entire market cap California facility, Canadian cannabis clinics add to company’s value Sunniva also bolstered by agreement with licensed producer Canopy Growth Corp. amid heightened M&A activity in cannabis sector Cannabis supplier Sunniva Inc.’s (CSE: SNN) (OTCQX: SNNVF) strengthening foothold in California’s and Canada’s consumer-populated markets has been failing to translate to its stock price and market cap since it began trading on the Canadian Securities Exchange and the U.S. OTCQX® Best Market in January, leading investment researchers at Beacon Securities Limited (http://cnw.fm/PhE2A) to classify Sunniva’s public offering as a…

Continue Reading

WednesdayAug 08, 2018 11:56 am

Cannabis Strategic Ventures, Inc. (NUGS) Does Deal for Clean Cannabis as New Regulations Take Effect

New regulations mandate cleaner, safer cannabis Cannabis concentrate extraction deal with CGMP-compliant facility Launch of Pure Organix with vape pen cartridges Appointment of CPG-experienced board member The deal that Cannabis Strategic Ventures, Inc. (OTC: NUGS) recently struck with Sunniva Inc. comes at a crucial time in the California cannabis industry. On July 1, new, stricter regulations came into force that caused quite a kerfuffle; retailers were forced to sell off non-compliant products in what has been labelled a “fire sale” of cannabis. As the industry develops, California state authorities appear to be building a robust regulatory regime, which will put…

Continue Reading

WednesdayAug 08, 2018 9:00 am

Specific Therapeutic Benefits of Cannabidiol (CBD) Validated by FDA

CannabisNewsWire Editorial Coverage: In a landmark announcement, the U.S. Food and Drug Administration (FDA) recently approved a drug derived from pure cannabidiol (CBD), Epidiolex, to treat seizures associated with certain forms of severe epilepsy, setting the stage for huge changes in the world of cannabidiol (CBD). FDA approval of a cannabis-based drug represents seismic political, legal and economic shifts Approval likely will lead to more clinical research and further validation of CBD therapeutic efficacy CBD market projected to explode to more than $2 billion in two years with 39 percent CAGR What’s most transformative about this drug approval is that…

Continue Reading

TuesdayAug 07, 2018 11:32 am

BLOCKStrain Technology Corp. (TSX.V: DNAX) Reaches Key Milestones toward Imminent Launch of Seed-to-Sale Cannabis Tracking Software

Major features finalized under aggressive deadline, with product launch mere weeks away Proprietary technology suite tracks cannabis end-to-end with blockchain-protected solution for growers, breeders Current cannabis testing system vulnerable, leaving consumers and producers exposed to risk Strategic partnership announced to implement BLOCKStrain platform’s benefits into regulatory framework for medical and adult-use cannabis in Canada Canada’s inexorable march toward full legalization of cannabis for the adult user in both the medical and recreational markets is much anticipated by the public and Vancouver, Canada-based BLOCKStrain Technology Corp. (TSX.V: DNAX). Major features of BLOCKStrain’s proprietary, end-to-end cannabis tracking platform are rapidly being finalized by…

Continue Reading

MondayAug 06, 2018 10:04 am

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) to Launch OKI Brand CBD-Infused Products in 3Q2018, Signs Agreement for Access to 2,400 Stores

PHVAF inks agreement with Acosta’s National Specialty Sales division to sell to 2,400 retailers across U.S., will later have access to 25,000 more supermarkets, such as Wal-Mart and Target Jim Bailey, PHVAF CEO and president, terms crossover distribution into mainstream national retailers a “significant milestone” for the CBD industry; market channel is valued at $4.1 billion OKI line to consist of CBD-infused beverages, such as iced tea and flavored infused waters, plus tinctures and capsules; it will be available to consumers in 3Q2018 Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) will launch its OKI brand of premium CBD products to…

Continue Reading

FridayAug 03, 2018 2:44 pm

Earth Science Tech, Inc. (ETST) Poised to Leverage Full-Spectrum CBD Product Line in Projected $2 Billion Market

Earth Science Tech to add three full-spectrum CBD chocolate offerings to product line Testing to begin on CBD-based patent products Earth Science Tech products will be available to 90,000 retail outlets throughout U.S. On the heels of a major decision by the U.S. Food and Drug Administration (FDA) to approve Epidiolex, a drug derived from pure cannabidiol (CBD), to treat seizures associated with certain forms of severe epilepsy, Earth Science Tech, Inc. (OTC: ETST) is repositioning its line of full-spectrum CBD offerings. Included in this move is the announcement that the company, along with joint venture partner Karmavore Superfoods, will…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722